Company Information & Drug Savings for Insys Therapeutics Medications

Insys Therapeutics was a specialty pharmaceutical company that developed Subsys (fentanyl sublingual spray) for breakthrough cancer pain. The company filed for bankruptcy following legal issues related to opioid marketing practices. Subsys continues to be available under other ownership for appropriate cancer pain patients.

Insys Therapeutics

How to Contact Insys Therapeutics

Browse Medications Manufactured by Insys Therapeutics

Medical Disclaimer

NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.

The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.

Experienced a Side Effect?

Report to

👉
Yellowcard logo
(UK)
👉
Medwatch logo
(US)
NowPatient - Report Side Effects to Yellow Card or MedWatch